NCT05250986

Brief Summary

GoCheck has developed and deployed a home-based visual acuity test that may be used in-office or in residence. The test methodology utilizes modified ATS and ETDRS protocols with Sloan optotypes, crowding bars and sophisticated algorithms. The objective of this study is to determine if the results of the GoCheck visual acuity test performed in an office setting correlate to the same testing when implemented in the residence

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
325

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2022

Shorter than P25 for all trials

Geographic Reach
2 countries

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

February 14, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 22, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

February 22, 2022

Status Verified

February 1, 2022

Enrollment Period

4 months

First QC Date

February 11, 2022

Last Update Submit

February 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation of in-office visual acuity results to visual acuity results obtained in residence.

    correlation of visual acuity results obtained by trained personnel utilizing the GoCheck Kids Visual Acuity solution in an in-office clinical setting compared to the results obtained by individuals conducting the same visual acuity test in their residence.

    10 Days

Secondary Outcomes (2)

  • Accuracy of in residence visual acuity results to opthalmic visual acuity

    10 Days

  • Repeatability and Reproducibility of Visual Acuity in Residence

    7 Days

Interventions

Visual Acuity method is used to measure of the sharpness or clearness of vision. Device: GoCheck Visual Acuity in Office (Windows) Photorefraction method is used to screen amblyopia risk factors.

Visual Acuity method is used to measure of the sharpness or clearness of vision.

Visual Acuity method is used to measure of the sharpness or clearness of vision.

Visual Acuity method is used to measure of the sharpness or clearness of vision.

Eligibility Criteria

Age4 Years - 20 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

English-speaking individuals of any gender, aged four to twenty years, with recent refraction, able to comprehend and complete the visual acuity test with age appropriate optotypes.

You may qualify if:

  • Ages four (4) to twenty(20) years, inclusive
  • Corrected visual acuity range of 20/16 to 20/100
  • Manifest or cycloplegic refraction within prior six (6) months
  • Ability to comprehend and complete the VA test with age appropriate optotypes

You may not qualify if:

  • No access to smartphone
  • Inability to read, write, and/or understand English
  • Inability to provide written informed consent or have consent conferred on patient's behalf
  • Subjects from populations otherwise deemed ineligible/unable to provide informed consent and/or participate in studies (detention, correction, rehabilitation, psychiatric residents, etc.)
  • Current pregnancy
  • Any ocular pathology defect(s) except amblyopia, strabismus or refractive error or history of nystagmus.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Alaska Children's Eye & Strabismus

Anchorage, Alaska, 99508, United States

RECRUITING

Yale School of Medicine, Yale University

New Haven, Connecticut, 06510, United States

NOT YET RECRUITING

Medical University of South Carolina-Storm Eye Institute

Charleston, South Carolina, 29425, United States

NOT YET RECRUITING

Stern Hospital

Haifa, Tel Aviv, Israel

RECRUITING

MeSH Terms

Conditions

Refractive Errors

Condition Hierarchy (Ancestors)

Eye Diseases

Study Officials

  • David Huang, MD

    Oregon Health and Science University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2022

First Posted

February 22, 2022

Study Start

February 14, 2022

Primary Completion

May 31, 2022

Study Completion

September 1, 2022

Last Updated

February 22, 2022

Record last verified: 2022-02

Locations